JP2019214579A5 - - Google Patents

Download PDF

Info

Publication number
JP2019214579A5
JP2019214579A5 JP2019132864A JP2019132864A JP2019214579A5 JP 2019214579 A5 JP2019214579 A5 JP 2019214579A5 JP 2019132864 A JP2019132864 A JP 2019132864A JP 2019132864 A JP2019132864 A JP 2019132864A JP 2019214579 A5 JP2019214579 A5 JP 2019214579A5
Authority
JP
Japan
Prior art keywords
capsid
viral vector
recombinant viral
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019132864A
Other languages
English (en)
Other versions
JP6768895B2 (ja
JP2019214579A (ja
Filing date
Publication date
Priority claimed from DE102013215817.3A external-priority patent/DE102013215817A1/de
Application filed filed Critical
Publication of JP2019214579A publication Critical patent/JP2019214579A/ja
Publication of JP2019214579A5 publication Critical patent/JP2019214579A5/ja
Application granted granted Critical
Publication of JP6768895B2 publication Critical patent/JP6768895B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (2)

  1. カプシド及びその中にパッケージングされた導入遺伝子を含む組み換えウイルスベクターであって、前記カプシドが配列番号9のアミノ酸配列を含む少なくとも1つのカプシドタンパク質を含む、前記組み換えウイルスベクター。
  2. 請求項1に記載の組み換えウイルスベクターを含む、薬学的組成物。
JP2019132864A 2013-08-09 2019-07-18 肺に対する特異性を有する新たなペプチド Active JP6768895B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013215817.3A DE102013215817A1 (de) 2013-08-09 2013-08-09 Neue peptide mit spezifität für die lunge
DE102013215817.3 2013-08-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016532677A Division JP6560212B2 (ja) 2013-08-09 2014-08-06 肺に対する特異性を有する新たなペプチド

Publications (3)

Publication Number Publication Date
JP2019214579A JP2019214579A (ja) 2019-12-19
JP2019214579A5 true JP2019214579A5 (ja) 2020-05-21
JP6768895B2 JP6768895B2 (ja) 2020-10-14

Family

ID=51383708

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016532677A Active JP6560212B2 (ja) 2013-08-09 2014-08-06 肺に対する特異性を有する新たなペプチド
JP2019132864A Active JP6768895B2 (ja) 2013-08-09 2019-07-18 肺に対する特異性を有する新たなペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016532677A Active JP6560212B2 (ja) 2013-08-09 2014-08-06 肺に対する特異性を有する新たなペプチド

Country Status (5)

Country Link
US (3) US10688151B2 (ja)
EP (2) EP3536794A3 (ja)
JP (2) JP6560212B2 (ja)
DE (1) DE102013215817A1 (ja)
WO (1) WO2015018860A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3073137A1 (en) 2016-08-19 2018-02-22 Jeffrey S. Bartlett Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus
KR20190088561A (ko) 2016-12-07 2019-07-26 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 인터류킨-1 수용체 길항제(IL-1RA) cDNA
KR20220011616A (ko) * 2019-03-21 2022-01-28 스트라이드바이오 인코포레이티드 재조합 아데노 관련 바이러스 벡터
WO2020221911A1 (en) 2019-05-02 2020-11-05 Boehringer Ingelheim International Gmbh Viral vectors and nucleic acids for use in the treatment of pf-ild and ipf
WO2021233849A1 (en) 2020-05-17 2021-11-25 Boehringer Ingelheim International Gmbh Viral vectors and nucleic acids for regulated gene therapy
US20230416738A1 (en) 2020-11-04 2023-12-28 Boehringer Ingelheim International Gmbh Viral vectors and nucleic acids for use in the treatment of ild, pf-ild and ipf
EP4240846A1 (en) 2020-11-04 2023-09-13 Boehringer Ingelheim International GmbH Viral vectors and nucleic acids for use in the treatment of ild, pf-ild and ipf
IL303891A (en) 2020-12-23 2023-08-01 Boehringer Ingelheim Int Viral capsid proteins with specificity for cardiac tissue cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083441A2 (en) * 2003-03-19 2004-09-30 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Random peptide library displayed on aav vectors
US7427396B2 (en) * 2004-06-03 2008-09-23 Genzyme Corporation AAV vectors for gene delivery to the lung
US10920244B2 (en) 2009-04-30 2021-02-16 The Trustees Of The University Of Pennsylvania Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
DE102014207498A1 (de) 2014-04-17 2015-10-22 Universitätsklinikum Hamburg-Eppendorf Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark

Similar Documents

Publication Publication Date Title
JP2019214579A5 (ja)
JP2020022459A5 (ja)
JP2018528253A5 (ja)
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
JP2018520997A5 (ja)
JP2015096070A5 (ja)
JP2019146574A5 (ja)
WO2019222136A3 (en) Liver targeting adeno-associated viral vectors
WO2017058892A3 (en) Methods and compositions for antibody-evading virus vectors
WO2018160582A8 (en) Adeno-associated virus (aav) clade f vector and uses therefor
WO2017066764A3 (en) Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
WO2020028751A3 (en) Aav variants with enhanced tropism
WO2019060454A3 (en) Adeno-associated virus variant capsids and methods of use thereof
JP2023082054A5 (ja)
EP3597760A3 (en) Adeno-associated virus vector
JP2018515096A5 (ja)
JP2016199557A5 (ja)
MX2017012097A (es) Variantes de virus adenoasociado y métodos de uso de estas.
JP2018506286A5 (ja)
JP2010065037A5 (ja)
JP2013172734A5 (ja)
JP2018529331A5 (ja)
WO2015158749A3 (de) Viraler vektor für den zielgerichteten gentransfer in gehirn und rückenmark
JP2019530462A5 (ja)
JP2017514522A5 (ja)